SEC Form 4 · accession 0000947871-16-001731
WebMD Health Corp. · WBMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James V Manning
Director
Period of report
Nov 28, 2016
Accepted (ET)
Nov 30, 2016 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 28, 2016 | S | 28,916 | $53.55 | D | 100,680 | D | |
| Common Stock | Nov 28, 2016 | M | 2,222 | $30.16 | A | 102,902 | D | |
| Common StockF2 | Nov 28, 2016 | F | 1,253 | $53.51 | D | 101,649 | D | |
| Common Stock | Nov 28, 2016 | M | 4,259 | $21.29 | A | 105,908 | D | |
| Common StockF3 | Nov 28, 2016 | F | 1,695 | $53.51 | D | 104,213 | D | |
| Common Stock | Nov 28, 2016 | M | 4,444 | $23.54 | A | 108,657 | D | |
| Common StockF4 | Nov 28, 2016 | F | 1,955 | $53.53 | D | 106,702 | D | |
| Common Stock | Nov 28, 2016 | M | 3,300 | $41.07 | A | 110,002 | D | |
| Common StockF5 | Nov 28, 2016 | F | 2,534 | $53.50 | D | 107,468 | D | |
| Common Stock | Nov 28, 2016 | M | 6,600 | $23.61 | A | 114,068 | D | |
| Common StockF6 | Nov 28, 2016 | F | 2,912 | $53.52 | D | 111,156 | D | |
| Common Stock | Nov 28, 2016 | M | 6,600 | $23.59 | A | 117,756 | D | |
| Common StockF7 | Nov 28, 2016 | F | 2,910 | $53.52 | D | 114,846 | D | |
| Common Stock | Nov 28, 2016 | M | 9,900 | $38.49 | A | 124,746 | D | |
| Common StockF8 | Nov 28, 2016 | F | 7,123 | $53.50 | D | 117,623 | D | |
| Common StockF9 | Nov 29, 2016 | S | 10,000 | $53.49 | D | 107,623 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F10 | $30.16 | Nov 28, 2016 | M | 2,222 | D | — | Jan 1, 2018 | Common Stock | 2,222 | 0 | D |
| Stock Option (right to buy)F10 | $21.29 | Nov 28, 2016 | M | 4,259 | D | — | Dec 10, 2018 | Common Stock | 4,259 | 0 | D |
| Stock Option (right to buy)F10 | $23.54 | Nov 28, 2016 | M | 4,444 | D | — | Jan 1, 2019 | Common Stock | 4,444 | 0 | D |
| Stock Option (right to buy)F11 | $41.07 | Nov 28, 2016 | M | 3,300 | D | — | Jan 1, 2018 | Common Stock | 3,300 | 0 | D |
| Stock Option (right to buy)F11 | $23.61 | Nov 28, 2016 | M | 6,600 | D | — | Dec 10, 2018 | Common Stock | 6,600 | 0 | D |
| Stock Option (right to buy)F11 | $23.59 | Nov 28, 2016 | M | 6,600 | D | — | Jan 1, 2019 | Common Stock | 6,600 | 0 | D |
| Stock Option (right to buy)F11 | $38.49 | Nov 28, 2016 | M | 9,900 | D | — | Jan 1, 2020 | Common Stock | 9,900 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.45 to $53.64 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- F1025% of the shares underlying the options vested on the first anniversary of the grant date and 1/48 of the shares vested monthly thereafter over the next three-year period (fully vested on the 4th anniversary of the grant date). The date of grant for each of these options was ten years prior to the expiration date.
- F1125% of the shares underlying the options vested on each of the first, second, third and fourth grant date anniversaries. The date of grant for each of these options was ten years prior to the expiration date.
- F2Mr. Manning received 969 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 2,222 shares of WebMD Common Stock, with the remaining 1,253 shares being retained by the issuer to pay the exercise price.
- F3Mr. Manning received 2,564 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 4,259 shares of WebMD Common Stock, with the remaining 1,695 shares being retained by the issuer to pay the exercise price.
- F4Mr. Manning received 2,489 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 4,444 shares of WebMD Common Stock, with the remaining 1,955 shares being retained by the issuer to pay the exercise price.
- F5Mr. Manning received 766 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 3,300 shares of WebMD Common Stock, with the remaining 2,534 shares being retained by the issuer to pay the exercise price.
- F6Mr. Manning received 3,688 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 6,600 shares of WebMD Common Stock, with the remaining 2,912 shares being retained by the issuer to pay the exercise price.
- F7Mr. Manning received 3,690 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 6,600 shares of WebMD Common Stock, with the remaining 2,910 shares being retained by the issuer to pay the exercise price.
- F8Mr. Manning received 2,777 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 9,900 shares of WebMD Common Stock, with the remaining 7,123 shares being retained by the issuer to pay the exercise price.
- F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.46 to $53.54 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (9) to this Form 4.